Clinical Trials Logo

Clinical Trial Summary

Pancreatic Cancer is a leading cause of cancer-related death. To date, only one fifth of patients at diagnosis is presented resectable because the diagnosis is often delayed making the 5-year survival of this disease globally less than 5%. An early diagnosis in these patients is currently not possible given the economic disadvantages of a population-wide screening. New evidences identify patients with new-onset diabetes as a subgroup of patients at high risk of developing this disease (RR 5:38). In a subset of these patients a mediator secreted by the tumor, the Adrenomedullin, could be responsible for the onset of diabetes. Our goal is therefore to assess the different impact of Pancreatic Cancer depending on Adrenomedullin values in patients with newly diagnosed diabetes mellitus.


Clinical Trial Description

The study is defined as prospective observational. The research project involves the recruitment prospectively for all consecutive patients aged between 45 and 75 years receiving a new diagnosis of diabetes, according to the criteria established by the American Diabetes Association (ADA) (fasting glucose greater than or equal 126 mg / dl, or random blood glucose greater than or equal to 200 mg / dl, or glycated hemoglobin greater than or equal to 6.25%). The recruitment will take place at the Sant'Andrea Hospital. The suitability of a subject to be included in the study will be evaluated by medical history, physical examination and any further investigations carried out by a medical researcher of the team, according to the inclusion and exclusion criteria. The research team will be multidisciplinary, translational, composed of medical specialists belonging to the departments of General Surgery, Internal Medicine, Diabetology and Occupational Medicine. An informed consent will be mandatory for the recruitment in the study. At recruitment Adrenomedullin serum levels will be recorded along with every relevant clinical and laboratory data. An annual telephone follow-up will be applied and if necessary the patient will benefit of an outpatient examination. A sample size of 440 patients will achieve 80% power to detect a statistically significant difference. The 3 years clinical follow-up will allow the detection of symptoms and signs that could be related to the presence of a pancreatic mass (jaundice, pain, weight loss), further investigations will follow in such cases to confirm Pancreatic cancer diagnosis and proceed to the treatment. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02456051
Study type Observational
Source University of Roma La Sapienza
Contact
Status Terminated
Phase N/A
Start date April 2015
Completion date November 2017

See also
  Status Clinical Trial Phase
Recruiting NCT03022721 - Heidelberg Study on Diabetes and Complications N/A
Withdrawn NCT02580266 - Blood/Urine Markers for Drug Discovery for Renal Disease in Diabetes
Completed NCT02423434 - Evaluation of Corneal Confocal Microscopy for the Identification and Prediction of Neuropathy in Type 1 Diabetes
Completed NCT01695278 - A Pilot Intervention Study of Health Coaching to Promote Diabetes Self-Care in the Community Phase 3
Completed NCT03426566 - Abnormal Plantar Pressure in Patients With Diabetes
Completed NCT02588898 - B-Vitamins and Polyneuropathy in Patients With Type 2 Diabetes
Completed NCT00815178 - Effects of Inspiratory Muscle Training on Type 2 Diabetes Mellitus Patients With Inspiratory Muscle Weakness N/A
Not yet recruiting NCT04537676 - Patient Empowerment Study
Terminated NCT02915263 - The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes Phase 2
Completed NCT01929018 - Collaborative-care Rehabilitation After Dysvascular Amputation N/A
Completed NCT03877523 - Cocarnit Effects on Macrophages Polarization N/A
Completed NCT02947828 - Polyneuropathy in Diabetes Mellitus Type 2
Completed NCT02928939 - Therapeutic Conflicts and Multimorbidity
Recruiting NCT02275091 - Children With Diabetes at Risk for Heart Disease.
Terminated NCT00529204 - Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease Phase 2
Not yet recruiting NCT05074849 - Benefits of Insoles With Real-Time Alert and Foot Self-Care Education N/A
Completed NCT04963998 - Safety and Efficacy Study of MedCu Wound Dressings N/A
Recruiting NCT06321029 - Electronic Diabetes Tune-Up Group (eDTU) for African Americans N/A
Active, not recruiting NCT03620773 - Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes Phase 1/Phase 2
Completed NCT05231642 - Individualised Postprandial Glucose Responses in Type 1 Diabetes N/A